In the US, Plaquenil (hydroxychloroquine systemic) is a member of the following drug classes: antimalarial quinolines, antirheumatics and is used to treat Dermatomyositis, Lyme Disease - Arthritis, Malaria, Malaria Prevention, Rheumatoid Arthritis, Sjogren's Syndrome, Systemic Lupus Erythematosus and Undifferentiated Connective Tissue Disease.
Ingredient matches for Plaquenil
Hydrochlorothiazide is reported as an ingredient of Plaquenil in the following countries:
Hydroxychloroquine is reported as an ingredient of Plaquenil in the following countries:
Hydroxychloroquine sulfate (a derivative of Hydroxychloroquine) is reported as an ingredient of Plaquenil in the following countries:
- Hong Kong
- New Zealand
- Russian Federation
- United Kingdom
Important Notice: The Drugs.com international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.